COMP <GO>
LFVN vs UNH // ENTERPRISE SCALE & MARKET CAP
Lifevantage Corporation (Delaware) (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: LFVN 10
— UNH 3
▲ ENTERPRISE SCALE & MARKET CAP LEADER: UNH
LAST: $5.88 (+0.17%) • MKT CAP: $73.9M
market-cap
$73.9M
LAST: $406.97 (-0.96%) • MKT CAP: $368.83B
market-cap
$368.83B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LFVN VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LFVN | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 80.40% | 88.57% | -8.17 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 29.20% | 11.47% | +17.73 | LFVN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.5x | 16.4x | -10.95 | LFVN | /valuation <GO> |
| Free Cash Flow Yield | 14.22% | 6.48% | +7.74 | LFVN | /fcf-yield <GO> |
| Operating Margin | 5.30% | 4.82% | +0.48 | LFVN | /operating-margins <GO> |
| Net Profit Margin | 4.30% | 3.14% | +1.16 | LFVN | /net-margins <GO> |
| Revenue Growth (YoY) | 14.20% | 6.46% | +7.74 | LFVN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.80% | 2.28% | +0.52 | LFVN | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.98 | 3.12 | +0.86 | LFVN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | LFVN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.6 | 59.2 | -9.58 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 6.3x | 17.7x | -11.44 | LFVN | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $73.9M | $368.83B | -$368.76B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LFVN REV | UNH REV | LFVN GROSS % | UNH GROSS % | LFVN FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $228.5M | $447.57B | 80.4% | 88.7% | $10.5M | $16.07B |
| FY 2024 | $200.2M | $400.28B | 79.3% | 88.3% | $10.0M | $20.70B |
| FY 2023 | $213.4M | $371.62B | — | 89.6% | $6.8M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LFVN // BETA —
UNH // BETA 0.33